Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Gilead Sciences Inc (GILD)  
$104.54 0.34 (0.32%) as of 4:30 Thu 4/17


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 1,250,000,000
Market Cap: 130.68(B)
Last Volume: 8,066,759 Avg Vol: 8,489,398
52 Week Range: $63.15 - $117.41
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:

    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     NASDAQ-100
    S&P 500     NASDAQ NNM COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  425
Guru Rank Value     : 4.8
Guru Occurances    : 3

 

            6 Months   1 Year   2 Year  
 
Company Profile   Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercializes medicines. Co.'s primary areas of focus include viral diseases, inflammatory diseases and oncology. Co.'s products include: Biktarvy® for the treatment of HIV-1 infection in certain patients; Veklury® (remdesivir), for the treatment of Coronavirus Disease 2019 requiring hospitalization; Epclusa® for the treatment of chronic hepatitis C virus infection; Vemlidy® for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease; Yescarta® (axicabtagene ciloleucel) for the treatment of adult patients with relapsed or refractory large B-cell lymphoma.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 305,285 766,519 836,125 874,583
Total Sell Value $30,817,227 $73,404,787 $79,113,020 $82,165,066
Total People Sold 1 4 4 4
Total Sell Transactions 6 13 19 28
End Date 2025-01-19 2024-10-18 2024-04-19 2023-04-20

   
Records found: 992
  Page 1 of 40  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Dickinson Andrew D Chief Financial Officer   •       •      –    2025-04-15 4 AS $106.40 $266,000 D/D (2,500) 168,174     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2025-03-17 4 AS $110.53 $276,325 D/D (2,500) 170,674 -8%     
   Wilfong Diane E Interim Corp Controller & CAOO   •       –      –    2025-03-12 3 IO $0.00 $0 D/D 0 45,096 -8%     
   Patterson Sandra SVP, Controllership   •       •      –    2025-03-10 4 D $117.21 $73,139 D/D (624) 39,453     -
   Patterson Sandra SVP, Controllership   •       •      –    2025-03-10 4 OE $0.00 $0 D/D 1,952 40,077     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2025-03-10 4 D $117.21 $451,845 D/D (3,855) 173,174     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2025-03-10 4 OE $0.00 $1,145,842 D/D 25,897 177,029     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2025-03-10 4 AS $117.30 $2,118,696 D/D (17,929) 169,061 -12%     
   Oday Daniel Patrick Chairman & CEO   •       •      –    2025-03-10 4 D $117.21 $1,363,387 D/D (11,632) 630,268     -
   Oday Daniel Patrick Chairman & CEO   •       •      –    2025-03-10 4 OE $0.00 $0 D/D 24,024 641,900     -
   Telman Deborah H EVP, Corporate Affairs & GC   •       •      –    2025-03-10 4 D $117.21 $132,447 D/D (1,130) 36,562     -
   Telman Deborah H EVP, Corporate Affairs & GC   •       •      –    2025-03-10 4 OE $0.00 $0 D/D 3,343 37,692     -
   Mercier Johanna Chief Commercial Officer   •       •      –    2025-03-10 4 D $117.21 $457,939 D/D (3,907) 124,152     -
   Mercier Johanna Chief Commercial Officer   •       •      –    2025-03-10 4 OE $0.00 $0 D/D 8,080 128,059     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2025-02-18 4 AS $104.09 $260,225 D/D (2,500) 169,061 -2%     
   Dickinson Andrew D Chief Financial Officer   •       •      –    2025-02-12 4 AS $102.22 $14,073,241 D/D (137,676) 171,223 0%     
   Dickinson Andrew D Chief Financial Officer   •       •      –    2025-02-12 4 OE $57.92 $9,260,873 D/D 137,676 308,899     -
   Telman Deborah H EVP, Corporate Affairs & GC   •       •      –    2025-02-04 4 A $0.00 $0 D/D 12,371 34,011     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2025-02-04 4 D $97.99 $4,227,093 D/D (43,138) 171,223     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2025-02-04 4 A $0.00 $0 D/D 84,488 214,361     -
   Oday Daniel Patrick Chairman & CEO   •       •      –    2025-02-04 4 D $97.99 $10,598,206 D/D (108,156) 617,876     -
   Oday Daniel Patrick Chairman & CEO   •       •      –    2025-02-04 4 A $0.00 $0 D/D 224,504 726,032     -
   Patterson Sandra SVP, Controllership   •       •      –    2025-02-04 4 A $0.00 $0 D/D 709 37,787     -
   Mercier Johanna Chief Commercial Officer   •       •      –    2025-02-04 4 D $97.99 $4,474,811 D/D (45,666) 119,979     -
   Mercier Johanna Chief Commercial Officer   •       •      –    2025-02-04 4 A $0.00 $0 D/D 90,505 165,645     -

  992 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 40
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed